 | LEV-15 | Microvesicles derived from human prostate adenocarcinoma (LnCAP cell line) | 1 Each | Sign In for Pricing | |
 | LEV-F665-LnCAP | Fluorescent labeled microvesicles derived from human prostate adenocarcinoma (LnCAP cell line) | 1 Each | Sign In for Pricing | |
 | BNCB2836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), Biotin conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNCB3350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), Biotin conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC683348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF568 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNCB2836-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), Biotin conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC882576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF488A conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNCB3348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), Biotin conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC043350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF405S conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC943348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF594 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC683348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF568 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC043347-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF405S conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC942576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF594 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNUB3348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC743348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF740 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNCB3348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), Biotin conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNCB2576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), Biotin conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC742576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF740 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC472836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNC882836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF488A conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| BNUB3347-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNUM2836-50 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), 1mg/mL | 1x 50 µL | Sign In for Pricing | |
 | BNUB2576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), 0.2mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC472576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC682576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF568 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC473350-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF647 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| BNC883347-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF488A conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC943350-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF594 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC042836-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF405S conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNUB3350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), 0.2mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC473347-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3347), CF647 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC403350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF640R conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
| TP242f | Top 4 types of cancer (colon, breast, lung and prosate) with normal tissue array, including colon adenocarcinoma, breast invasive carcinoma of no special type, prostate adenocarcinoma, lung squamous cell carcinoma, lung adenocarcinoma, grade, TNM and clinical state (AJCC 8.0), 24 cases/24 cores (core size 1.5mm) ，replacing TP242e，Recent Year Collection | 1 Each | Sign In for Pricing | |
 | BNC472836-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF647 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC943350-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF594 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC743350-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF740 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC472576-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF647 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC742836-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2836), CF740 conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNUB3348-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), 0.2mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC403348-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF640R conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
 | BNC682576-500 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/2576), CF568 conjugate, 0.1mg/mL | 1x 500 µL | Sign In for Pricing | |
 | BNC403350-100 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3350), CF640R conjugate, 0.1mg/mL | 1x 100 µL | Sign In for Pricing | |
| PR781 | Prostate adenocarcinoma, hyperplasia, NAT and normal tissue array, including pathology grade, TNM/Stage (AJCC 8.0), Gleason grade, Gleason score, 78 cases/78 cores (core size 1.5mm), replacing PR807c. | 1 Each | Sign In for Pricing | |
| T191b | Prostate adenocarcinoma test tissue array, with prostate control tissues, pathology grade, TNM and clinical stage (AJCC 8.0), 6 cases/24 cores, replacing T191a (1.5mm) | 1 Each | Sign In for Pricing | |
| EXA-0822-CY185 | Fluorescent labeled exosomes from LnCAP cell line (human prostate adenocarcinoma) cell culture media | 100 µL (> 1x 10^9 PaRoom Temperatureicles/Vial) | Sign In for Pricing | |
| ALHC014-GFP | GFP-Human PC3 Prostate Adenocarcinoma Cells | 1ml frozen Vial | Sign In for Pricing | |
| MBS640734-01 | Tissue, Section, Human Tumor, Prostate Tumor, Adenocarcinoma (Paraffin) | 5 Sections | Sign In for Pricing | |
| MBS640734-02 | Tissue, Section, Human Tumor, Prostate Tumor, Adenocarcinoma (Paraffin) | 5x 5 Sections | Sign In for Pricing | |
| MBS4381119-01 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 0.02 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |
| MBS4381119-02 | NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) | 0.1 mg (With BSA & Azide at 0.2mg/mL) | Sign In for Pricing | |